As of 12/31/2024, Tracenable has captured detailed data on Biogen's corporate ownership structure, offering an in-depth view of its significant subsidiaries and their importance within the group.a
The dataset includes information on 94 subsidiaries, identified as material based on their financial importance, operational scale, or strategic contribution to Biogen's consolidated operations.a
| Entity Name | Country | Type | Ownership | LEI | PermID |
|---|---|---|---|---|---|
Biogen Belgium N.V./S.A.a | BEL | Subsidiary | Not Specified | 0000000 | 0000000 |
Biogen U.S. West Corporationa | USA | Subsidiary | Not Specified | 0000000 | 0000000 |
Conforma Therapeutics Corporationa | USA | Subsidiary | Not Specified | 0000000 | 0000000 |
Human Immunology Biosciences, Inc.a | USA | Subsidiary | Not Specified | 0000000 | 0000000 |
Stromedix, LLCa | USA | Subsidiary | Not Specified | 0000000 | 0000000 |
Nightstar, Inc.a | USA | Subsidiary | Not Specified | 0000000 | 0000000 |
Reata Pharmaceuticals Global, Inc.a | USA | Subsidiary | Not Specified | 0000000 | 0000000 |
Reata Pharmaceuticals Holdings, LLC.a | USA | Subsidiary | Not Specified | 0000000 | 0000000 |
Reata Pharmaceuticals, Inc.a | USA | Subsidiary | Not Specified | 0000000 | 0000000 |
Biogen (Argentina) SRLa | ARG | Subsidiary | Not Specified | 0000000 | 0000000 |
Biogen Australia PTY Ltda | AUS | Subsidiary | Not Specified | 0000000 | 0000000 |
Reata Australia PTY Ltda | AUS | Subsidiary | Not Specified | 0000000 | 0000000 |
| 0000000 | 0000000 | 0000000 | 0000000 | 0000000 | 0000000 |
| 0000000 | 0000000 | 0000000 | 0000000 | 0000000 | 0000000 |
| Showing 12 out of 94 entities. Get complete coverage in the full dataset. | |||||
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Biogen’s data sources below and access millions more through our Disclosure Search.
Tracenable's group entities dataset provides geographic insights into Biogen's significant subsidiaries, revealing their location around the world.a
In total, the Biogen group includes 94 significant subsidiaries distributed across 44 countries, illustrating the company's governance network, operational footprint, and geographical consolidation structure.a
This visualization highlights the geographical distribution of Biogen's corporate structure, helping assess its international exposure, operational reach, and cross-border governance landscape.a
In 2024, Tracenable identified that the Biogen group consisted of94 significant subsidiaries, located across 44 countries.a
This represents a focused geographic presence, reflecting the company's core operational centers or key strategic markets rather than a full view of its global entity network.a
Biogen's significant subsidiaries are primarily located in Europe and North America, which together host 80.85% of its material entities.a
This concentration suggests that the company's strategic and operational priorities are centered in these key markets, consistent with its focus on financially material or high-impact operations.
Biogen exhibits a limited level of transparency concerning its corporate ownership structure.
The disclosure covers only a small number of significant subsidiaries, typically those with material financial or operational relevance.a
Without full group hierarchy or equity details, it offers a restricted view of Biogen's broader ownership network, making it harder to assess the company's consolidated structure or cross-entity control.
Yes. Tracenable's data shows that 2 entities (2.13%) are registered in jurisdictions commonly classified as low-tax or offshore financial centers, such as Bermuda.a
This may indicate tax optimization strategies or the use of special-purpose vehicles (SPVs) within Biogen's ownership structure.